JPH0464588B2 - - Google Patents
Info
- Publication number
- JPH0464588B2 JPH0464588B2 JP60173009A JP17300985A JPH0464588B2 JP H0464588 B2 JPH0464588 B2 JP H0464588B2 JP 60173009 A JP60173009 A JP 60173009A JP 17300985 A JP17300985 A JP 17300985A JP H0464588 B2 JPH0464588 B2 JP H0464588B2
- Authority
- JP
- Japan
- Prior art keywords
- reticulocytes
- fluorescence
- blood cells
- staining
- red blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
- G01N15/1459—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals the analysis being performed on a sample stream
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
- G01N2015/012—Red blood cells
- G01N2015/014—Reticulocytes
Landscapes
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Description
【発明の詳細な説明】
産業上の利用分野
本発明はフローサイトメトリーを応用した血液
の光学的測定技術特に近時その計数の重要性を増
した未成熟(網状)赤血球の測定方法に関する。DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to an optical measurement technique for blood using flow cytometry, and particularly to a method for measuring immature (reticuloid) red blood cells, whose counting has recently become increasingly important.
従来の技術
血液試料中の未成熟の赤血球は網状赤血球(レ
チクロサイトReticulocyto.RETとも略記)と称
せられ、通常全赤血球中0.7〜2.2%がこれにあた
り、網状赤血球数の測定によつて急性内出血、溶
血性貧血、産生不良性貧血その他の各種診断を裏
付けるため近時の臨床検査に重要視されてきた。Conventional technology Immature red blood cells in a blood sample are called reticulocytes (also abbreviated as reticulocytes.RET), and usually account for 0.7 to 2.2% of all red blood cells.Acute internal bleeding can be detected by measuring the reticulocyte count. In recent years, it has become important in clinical tests to support various diagnoses such as hemolytic anemia, poor production anemia, and others.
上記網状赤血球の計数には当初ニユーメチレン
ブルー、ブリリアントクレゾールブルー等の塩基
性染料により染色された塗沫血液が用いられ、全
赤血球を顕微鏡で観察しながら発色した網状赤血
球の割合を計数することが行われた。 Initially, smeared blood stained with basic dyes such as new methylene blue and brilliant cresol blue was used to count the reticulocytes, and the percentage of colored reticulocytes was counted while observing all the red blood cells under a microscope. I was disappointed.
上掲の各種染料による染色には血液試料の前処
理、染色後の目視算定に時間と労力を要し、検査
数の大きい場合に不適当であつた。 Staining with the above-mentioned various dyes requires time and labor for pretreatment of blood samples and visual calculation after staining, and is not suitable for cases where a large number of tests are to be performed.
そこで開発されたフローサイトメトリーによる
血液検査は高速化、精度の向上を達成しつつある
がなお未だ網状赤血球計数について問題が残され
ている。 Blood testing using flow cytometry, which was developed there, has become faster and more accurate, but problems still remain regarding reticulocyte counting.
従来技術のうち、米国特許第4336029号、同第
4325706号、同第4284412号は網状赤血球の染色に
アクリジンオレンジを用いることを提案してい
る。このアクリジンオレンジは網状赤血球中の
RNA成分に吸着されて赤色蛍光を発し、緑色蛍
光が主体の成熟赤血球と区別して計数可能にす
る。しかし、アクリジンオレンジの場合、(A)染色
溶液それ自体のバツクグランド蛍光が強く、血球
由来の蛍光強度測定に背景雑音となり誤差を生じ
易い、(B)蛍光が赤色領域の630nm以上であるた
め、高感度の蛍光測光装置が必要、(C)非特異染色
の度合が強く、成熟赤血球の中に赤色蛍光を発生
させるため、検体間誤差の小さい染色液組成の調
整が難しい、(D)血小板を強く染色するため、測定
中に血小板と赤血球が同時通過すると成熟赤血球
の散乱光強度と血小板の赤色蛍光強度とが同時測
定され、これが網状赤血球相当の信号レベルを構
成するので誤差の原因となる、(E)アクリジンオレ
ンジ溶液は環境依存性が大きく蛍光強度が変化し
易い、などの問題があつた。 Among the prior art, U.S. Patent No. 4336029,
No. 4325706 and No. 4284412 propose the use of acridine orange for staining reticulocytes. This acridine orange is found in reticulocytes.
It is adsorbed to RNA components and emits red fluorescence, making it possible to distinguish it from mature red blood cells, which mainly emit green fluorescence, and to count them. However, in the case of acridine orange, (A) the background fluorescence of the staining solution itself is strong, which tends to cause background noise and errors in measuring the fluorescence intensity derived from blood cells, and (B) the fluorescence is in the red region of 630 nm or more. A highly sensitive fluorescence photometer is required. (C) The degree of non-specific staining is strong and red fluorescence is generated in mature red blood cells, making it difficult to adjust the composition of the staining solution with small errors between specimens. (D) Platelet Because it is strongly stained, if platelets and red blood cells pass through it simultaneously during measurement, the scattered light intensity of mature red blood cells and the red fluorescence intensity of platelets will be measured simultaneously, and this will constitute a signal level equivalent to reticulocytes, causing errors. (E) Acridine orange solution had problems such as being highly environmentally dependent and the fluorescence intensity easily changing.
また、特開昭59−142465号公報においては染料
としてチオフラビンTの使用を開示している。こ
れは、血液試料のRNA染色を行つた後希釈や洗
浄によつて背景蛍光及び成熟赤血球の非特異蛍光
を減少させたうえで網状赤血球のRNA蛍光をフ
ローサイトメータで検出測定するものであるが、
(F)上記希釈を通じて非特異蛍光の低減に伴ない同
時にRNA結合の染料による特異蛍光も低減する
ため、蛍光感度の高い測定装置が要求される。ま
た、(G)希釈後は蛍光強度の経時的低下が激しくな
るので再現性の高いデータが得られない又(G′)
染色に比較的時間がかかるという問題があつた。 Further, Japanese Patent Application Laid-Open No. 142465/1983 discloses the use of Thioflavin T as a dye. This involves performing RNA staining on a blood sample, reducing background fluorescence and non-specific fluorescence of mature red blood cells through dilution and washing, and then detecting and measuring the RNA fluorescence of reticulocytes with a flow cytometer. ,
(F) As the non-specific fluorescence is reduced through the above dilution, the specific fluorescence due to the RNA-bound dye is also reduced at the same time, so a measuring device with high fluorescence sensitivity is required. In addition, after (G) dilution, the fluorescence intensity decreases rapidly over time, making it difficult to obtain highly reproducible data.
There was a problem that dyeing took a relatively long time.
さらに、ピロニンYを染料として用いることも
行われたが、これは固定した赤血球をRNA染色
してから洗浄して非特異蛍光及び背蛍光を完全に
除いた後、RNA結合の染料による特異蛍光を測
定するものである。この染料によれば、(H)血球の
事前固定処理、染色、洗浄の各工程に要する時間
が大きく他の方式の数十倍の所要時間がかかるた
め多検体処理には適当でない、(I)ピロニンYその
ものの蛍光量子収率がきわめて低く、このため高
出力レーザ光源による励起によつてはじめて測定
可能になる、(J)ピロニンYは低重合度のRNA、
DNAとしか結合しないので特異蛍光を得るべき
RNA染色の効率が低い、などの問題があつた。 Furthermore, pyronine Y was also used as a dye, but after staining fixed red blood cells with RNA and washing to completely remove non-specific fluorescence and back fluorescence, the specific fluorescence caused by the RNA-binding dye was detected. It is something to be measured. According to this dye, (H) the pre-fixation of blood cells, staining, and washing steps require a large amount of time, several tens of times longer than other methods, so it is not suitable for processing multiple samples; (I) The fluorescence quantum yield of pyronine Y itself is extremely low, so it can only be measured by excitation with a high-power laser light source. (J) Pyronine Y is an RNA with a low degree of polymerization.
Since it only binds to DNA, specific fluorescence should be obtained.
There were problems such as low RNA staining efficiency.
発明が解決しようとする問題点
従来使用されているフローサイトメトリーによ
る染色網状赤血球計数に避け難い前述のごとき、
アクリジンオレンジの場合ノ(A)〜(E)、チオフラビ
ンTの場合の(F)〜(G′)、ピロニンYの場合の(H)
〜(J)のすべての問題点を及ぶ限り除去し得る染料
物質を選択使用して、染色試料中の網状赤血球の
蛍光強度を著しく増強させ、その反面試料溶液に
ついてはその背景蛍光を低下させて蛍光測定にお
けるS/N比を高め、網状赤血球の特に低濃度又
は低RET比率域での測定精度を格段に向上せし
めることが本発明の解決しようとする課題であ
る。Problems to be Solved by the Invention The above-mentioned problems are unavoidable when counting stained reticulocytes using conventional flow cytometry.
(A) to (E) for acridine orange, (F) to (G') for thioflavin T, (H) for pyronine Y
By selectively using a dye substance that can eliminate to the greatest extent all of the problems in (J), the fluorescence intensity of reticulocytes in the stained sample is significantly enhanced, while the background fluorescence of the sample solution is reduced. The problem to be solved by the present invention is to increase the S/N ratio in fluorescence measurement and to significantly improve the measurement accuracy of reticulocytes, especially in the low concentration or low RET ratio range.
問題点を解決するための手段
本発明は、上記の問題点を解決し、全血液試料
中の赤血球について、成熟赤血球郡と未成熟赤血
球であつてRNAの多い網状赤血球群とをRET比
率の多少、赤血球群度の大小等に影響されること
なく鮮烈かつ強固な蛍光染色を網状赤血球群に施
こしその染色蛍光強度を著しく増強して網状赤血
球の高精度の識別を可能にするものであり、その
ために本発明は網状赤血球を蛍光染色するためオ
ーラミンOを含有する試薬を用いること、この試
薬の使用量を試料血液中のRNAを析出せしめる
よりも過剰量とすることを特徴とするフローサイ
トメトリーによる血球測定方法を実現したもので
ある。光学的測定に際し血球形状を安定化させる
ために、塩化ナトリウム等のアルカリ金属塩を添
加して染色液試薬を等張にし、また血液細胞の染
色効率を高めるために緩衝剤を添加することもで
きる。Means for Solving the Problems The present invention solves the above problems, and for red blood cells in a whole blood sample, the RET ratio of mature red blood cells and reticulocytes, which are immature red blood cells and have a high amount of RNA, is adjusted to a certain degree. , which applies vivid and strong fluorescent staining to the reticulocyte group without being affected by the size of the red blood cell group, and significantly enhances the staining fluorescence intensity, making it possible to identify reticulocytes with high precision. To this end, the present invention provides a flow cytometry method characterized in that a reagent containing auramine O is used to fluorescently stain reticulocytes, and the amount of this reagent used is in excess of that used to precipitate RNA in sample blood. This is a method for measuring blood cells. In order to stabilize the blood cell shape during optical measurement, an alkali metal salt such as sodium chloride can be added to make the staining solution reagent isotonic, and a buffer can also be added to increase the efficiency of staining blood cells. .
蛍光染料としてのオーラミンOは
または
が用いられる。これらのオーラミンOは染色血球
に対して鮮明な色相を与えるとともにそれ自体の
着色力も大である。 Auramine O as a fluorescent dye or is used. Auramine O gives a clear hue to stained blood cells, and also has great coloring power itself.
染料の分量が少なく、蛍光強度が低く、かつ散
乱強度分布にまとまりがない場合、蛍光増大作用
を有する固定剤例えばグルタルアルデヒドを少量
添加すると網状赤血球及び成熟赤血球の蛍光強度
と散乱光強度の均一化が達成される。散乱光強度
の増大作用はトリトンX−100の添加により調整
し適切な検出レベルに保つことが可能である。こ
のようにして溶液の背景蛍光を相対的に抑制し、
さらに網状赤血球の散乱光強度分布におけるまと
まりをよくし、これと同時に膜粘性を下げ血球相
互の付着を防止してその弁別計数をより一層たや
すくし、網状赤血球の測定精度を格段に向上す
る。 When the amount of dye is small, the fluorescence intensity is low, and the scattered intensity distribution is not uniform, adding a small amount of a fixative that has a fluorescence-enhancing effect, such as glutaraldehyde, can equalize the fluorescence intensity and scattered light intensity of reticulocytes and mature red blood cells. is achieved. The effect of increasing the intensity of scattered light can be adjusted by adding Triton X-100 and maintained at an appropriate detection level. In this way, the background fluorescence of the solution is relatively suppressed,
Furthermore, it improves the unity of the scattered light intensity distribution of reticulocytes, and at the same time lowers the membrane viscosity and prevents adhesion of blood cells to each other, making it easier to differentiate and count them, thereby significantly improving the measurement accuracy of reticulocytes.
オーラミンOは試薬1ml当り30〜2500μgrの含
有量が、又塩化ナトリウムなどのアルカリ金属塩
は1mlり当5〜20mgrでよく、PHは6−10に調整
することが好適である。上述した組成分を有する
等張緩衝染料溶液はEDTAなどで抗凝固化した
全血液試料と混合するための血球測定特に網状赤
血球測定用試薬となり、本発明ではこの試薬を、
検体中の血球細胞に含まれるRNAと化合して費
消されるオーラミンOの分量を基準にしてこの基
準を十分に越える過剰量の試薬を使用することを
特色とする。なお、上記試薬そのものに関しては
本出願人により特願昭60−12328号として出願さ
れている。 The content of auramine O may be 30 to 2500 μgr per ml of the reagent, and the content of alkali metal salts such as sodium chloride may be 5 to 20 mgr per ml, and the pH is preferably adjusted to 6-10. The isotonic buffered dye solution having the above-mentioned composition is a reagent for blood cell measurement, particularly reticulocyte measurement, to be mixed with a whole blood sample anticoagulated with EDTA, etc., and in the present invention, this reagent is used to
The method is characterized by using an excessive amount of reagent that sufficiently exceeds the amount of auramine O that is consumed by combining with RNA contained in blood cells in the specimen as a standard. The above reagent itself has been filed by the present applicant as Japanese Patent Application No. 12328/1983.
上記オーラミンO含有の血球測定用試薬を抗凝
固性全血液試料に混合すると、オーラミン染料が
網状赤血球を含む血球をすべて鮮烈に染色して細
胞中のRNAと結合してこれを析出させ蛍光染色
する。このオーラミンOによる染色状態は、界面
活性剤により蛍光及び散乱光が共に増強されて1
時間以上持続するが、さらにアルデヒド類による
背景蛍光の抑制作用が重なつて、これらが綜合さ
れ従来の試薬に比して網状赤血球の弁別計数精度
は大幅に向上する。本発明では又析出したRNA
の連鎖状分子に特異吸着された蛍光染色に加え、
RNAを含む多の網状物質にオーラミンが非特異
吸着される過剰量のオーラミンを用いており、こ
のため網状赤血球を含む血球濃度が低い場合や低
RET比率の血液試料についても網状赤血球の蛍
光強度が著しく増強されて目視計数と比べ測定デ
ータのばらつきが殆んどなくなり診断データの高
い信頼性を与えるものとなる。染色された網状赤
血球は、アルゴンイオンレーザ、キセノン又は水
銀アークランプ、ヘリウム−カドミウムレーザ等
を好適とする励起光源で紫色光ないし青色光を照
射し発生する約450〜700nm程度の蛍光をフロー
サイトメータで検出することにより弁別計数され
る。この試薬によりフローサイトメータで網状赤
血球を測定する場合、その組成はオーラミンO:
30〜2000μgr/ml、NaCl:8〜13mgr/ml、グル
タルアルデヒド:0〜500μgr/ml、トリトンX
−100:0〜100μgr/ml、緩衝剤としてのリン
酸、ホウ酸、バルビタール:0.01〜0.2M/、
残り水で全体を1にしPH7.0〜9.0に調整すると
好適である。 When the above reagent for blood cell measurement containing auramine O is mixed with an anticoagulant whole blood sample, the auramine dye vividly stains all blood cells, including reticulocytes, and binds to RNA in the cells to precipitate it, resulting in fluorescent staining. . This state of staining with auramine O is caused by both fluorescence and scattered light being enhanced by the surfactant.
This lasts for more than a few hours, and combined with the effect of suppressing background fluorescence by aldehydes, these factors are combined to greatly improve the accuracy of reticulocyte discrimination and counting compared to conventional reagents. In the present invention, the precipitated RNA
In addition to fluorescent staining specifically adsorbed to chain molecules,
An excessive amount of auramine is used, which causes it to be non-specifically adsorbed to the multi-reticular substance containing RNA.
For blood samples with a RET ratio, the fluorescence intensity of reticulocytes is significantly enhanced, and compared to visual counting, there is almost no variation in measurement data, resulting in highly reliable diagnostic data. The stained reticulocytes are irradiated with violet or blue light using an excitation light source such as an argon ion laser, xenon or mercury arc lamp, helium-cadmium laser, etc., and the generated fluorescence of approximately 450 to 700 nm is detected using a flow cytometer. Discriminative counting is performed by detecting with . When measuring reticulocytes with a flow cytometer using this reagent, its composition is auramine O:
30-2000μgr/ml, NaCl: 8-13mgr/ml, glutaraldehyde: 0-500μgr/ml, Triton X
-100: 0 to 100μgr/ml, phosphoric acid, boric acid, barbital as buffer: 0.01 to 0.2M/,
It is preferable to bring the whole to 1 with the remaining water and adjust the pH to 7.0 to 9.0.
作 用
従来のアクリジンオレンジによる染色法では、
第3図の斜線部分の示す網状赤血球が発する蛍光
を全部測光することが望ましいにも拘らず、網状
赤血球の特異染色と成熟赤血球や溶液自体の非特
異染色が競合し成熟赤血球自体が染色されること
になり被測定波長域で重なり、このため網状赤血
球のみを検出することができない。第3図に見
る如く、成熟赤血球による背後蛍光の影響を受け
ることなく蛍光測光ができる波長域が極めて小さ
いことが分かる。一方、網状赤血球を多く含む検
体では、試薬中の染料が一定であつたため特異染
色に必要な染料が不足し、第3図に示す様に網
状赤血球による蛍光強度が弱小になる。また、赤
血球数が小なく染料が過剰となると共に染料が吸
着しやすい血球試料の場合、第3図に示す如く
成熟赤血球、網状赤血球ともに信号強度が増大し
特異吸着の弁別が益々困難になる。このような信
号強度の相対的変化は第4図に比較されている。
従つて、アクリジンオレンジ法では、試料中の探
索する血球数をある程度予め調整しておき、その
うえでさらに特異吸着を最大に非特異吸着を最小
にする染料濃度を決定し、受光フイルター及び網
状赤血球検知レベルの決定で再現性と精度の確認
をすることが必要であつた。Effects In the conventional staining method using acridine orange,
Although it is desirable to measure all the fluorescence emitted by reticulocytes, which is shown in the shaded area in Figure 3, the specific staining of reticulocytes competes with the non-specific staining of mature red blood cells and the solution itself, and the mature red blood cells themselves are stained. As a result, they overlap in the wavelength range to be measured, making it impossible to detect only reticulocytes. As shown in FIG. 3, it can be seen that the wavelength range in which fluorescence photometry can be performed without being affected by background fluorescence from mature red blood cells is extremely small. On the other hand, in a specimen containing a large amount of reticulocytes, since the dye in the reagent was constant, the dye necessary for specific staining is insufficient, and the fluorescence intensity due to reticulocytes becomes weak as shown in FIG. In addition, in the case of a blood cell sample with a small number of red blood cells and an excess of dye, and the dye is easily adsorbed, the signal intensity of both mature red blood cells and reticulocytes increases as shown in FIG. 3, making it increasingly difficult to distinguish specific adsorption. Such relative changes in signal strength are compared in FIG.
Therefore, in the acridine orange method, the number of blood cells to be detected in the sample is adjusted to some extent in advance, and then the dye concentration that maximizes specific adsorption and minimizes non-specific adsorption is determined, and the light receiving filter and reticulocyte detection level are adjusted. It was necessary to check the reproducibility and accuracy in the determination.
ピロニンY、チオフラビンT法ではRNAを最
大染色した場合、第5図に示す様に成熟赤血球
同士の蛍光強度比が小さくしかも溶液蛍光から血
球信号を弁別することが難しい状態になる。この
ため、実際の測定時は希釈で溶液及び成熟赤血球
による背後蛍光を低減させているが、第5図に
示す如くRNA自体に基づく特異蛍光を含めて血
球信号が著しく小さくなり測光に支障を来たすに
至る。 In the pyronin Y and thioflavin T method, when RNA is stained to the maximum, the fluorescence intensity ratio between mature red blood cells is small and it is difficult to distinguish blood cell signals from solution fluorescence, as shown in FIG. For this reason, during actual measurements, background fluorescence due to the solution and mature red blood cells is reduced by dilution, but as shown in Figure 5, the blood cell signal, including the specific fluorescence based on the RNA itself, becomes extremely small, which interferes with photometry. leading to.
染料にオーラミンOを用いた場合、第1図aに
示す様に、溶液による背後蛍光及び粘性の比較的
低い成熟赤血球などに吸着された染料による蛍光
強度は小さく網状赤血球による蛍光強度は相対的
に大きい。従つて、網状赤血球の多い検体におい
てもRNAが完全に染色されるだけの染料を含有
する試薬量で網状赤血球を成熟赤血球から十分に
弁別することができる。染色によつて、網状赤血
球内にはRNA、リボソーム、ミトコンドリヤ、
ゴルジ体などの集積物からなる網状物質が析出沈
殿し、染料が過剰であると第1図bに示す如く、
これらの物質の酸性部位に吸着され、このため、
吸着された全ての染料がRNAに吸着されたBと
同程度の高い量子収率の光Cを発するので網状物
質全体が網状赤血球の弁別に寄与する。すなわち
網状物質は第1図bのB,Cの蛍光強度を発生し
第2図に明らかな様に溶液及び成熟赤血球による
Aをはるかにしのぐ。かくして、オーラミンOを
過剰に用いる染料で、この染料は従来法の如く網
状赤血球の測定に悪影響を及ぼすことはなく、反
対に、成熟赤血球に極めて近く網状物質それ自体
の少ない網状赤血球さえも検出可能にし、この場
合測光装置に様々な蛍光感度改善策を施す必要が
ない。 When auramine O is used as the dye, as shown in Figure 1a, the background fluorescence from the solution and the fluorescence intensity from the dye adsorbed to relatively low viscosity mature red blood cells are small, and the fluorescence intensity from reticulocytes is relatively small. big. Therefore, even in a specimen containing a large amount of reticulocytes, reticulocytes can be sufficiently distinguished from mature red blood cells with an amount of reagent containing enough dye to completely stain RNA. Staining reveals that RNA, ribosomes, mitochondria,
As shown in Figure 1b, if a network substance consisting of aggregates such as Golgi bodies precipitates and there is an excess of dye,
It is adsorbed on the acidic sites of these substances and, therefore,
Since all the adsorbed dyes emit light C with a quantum yield as high as B adsorbed on RNA, the entire reticular material contributes to the discrimination of reticulocytes. That is, the reticular substance generates the fluorescence intensity of B and C in FIG. 1b, which far exceeds the intensity of A caused by the solution and mature red blood cells, as is clear from FIG. Thus, with a dye that uses auramine O in excess, this dye does not adversely affect the measurement of reticulocytes as with conventional methods, and on the contrary, it is possible to detect even reticulocytes that are very close to mature red blood cells and have little reticulum itself. In this case, there is no need to implement various fluorescence sensitivity improvement measures on the photometric device.
実施例
オーラミンO:1gr、塩化ナトリウム:9grに
0.01M/リン酸緩衝液と水とを加えて1とし
PH7.20の黄色の試薬を調整した。この試薬10mlに
EDTA抗凝固新鮮血10μを加え、実温で30秒間
インキユベートした後蛍光フローサイトメータに
送入した。光源は約500nmの励起光を発生する
アルゴンイオンレーザを用い、520nm以上の蛍
光を受光検出した。前方散乱光−後方蛍光で検出
した網状赤血球の含有比率の高い0.1〜26%RET
の30検体について測定した。この場合の測定デー
タと目視計数データとの相関は低RET試料でも
極めて高かつた。Example Auramine O: 1gr, sodium chloride: 9gr
Add 0.01M/phosphate buffer and water to make 1.
A yellow reagent with a pH of 7.20 was prepared. 10ml of this reagent
10μ of EDTA anticoagulated fresh blood was added, incubated at room temperature for 30 seconds, and then transferred to a fluorescence flow cytometer. The light source used was an argon ion laser that generated excitation light of approximately 500 nm, and fluorescence of 520 nm or more was received and detected. Forward scattered light - 0.1-26% RET with high reticulocyte content detected by backward fluorescence
Measurements were made on 30 samples. In this case, the correlation between measurement data and visual counting data was extremely high even for low RET samples.
効 果
以上に述べた様に、オーラミンOを含有する蛍
光染色試薬を血液試料に対して十分過剰量混合し
て染色すると次のような蛍光フローメータにとつ
て極めて特有の効果がもたらされる:
(1) 成熟赤血球と網状赤血球との蛍光強度信号差
が大きく、両者の及び溶液蛍光との間の信号弁
別精度がより一層向上する。これに関連して、
生成直後の未成熟状態から次第に成熟赤血球に
近づいた網状赤血球や、もともと血球細胞内に
RNAなど網状物質が少ないものでもこれを成
熟赤血球、血小板等から高い精度で弁別し得
る。従つて、低RET比率の試料溶液で網状赤
血球の見逃しが殆んどない。Effects As mentioned above, when a blood sample is dyed with a fluorescent staining reagent containing auramine O in a sufficient excess amount, the following very specific effects for the fluorescent flow meter are brought about: ( 1) The difference in fluorescence intensity signals between mature red blood cells and reticulocytes is large, and the accuracy of signal discrimination between both and solution fluorescence is further improved. In this connection,
Reticulocytes that gradually approach mature red blood cells from an immature state immediately after generation, and
Even substances with a small amount of reticular substances, such as RNA, can be distinguished from mature red blood cells, platelets, etc. with high accuracy. Therefore, in a sample solution with a low RET ratio, reticulocytes are almost never missed.
(2) 染色時間が極めて短い。アクリジンオレンジ
法は5分間染色だが、RET=2〜3%を超え
ると染色終了に10分以上を要する。過剰オーラ
ミンOによる染色ではRET=13%の検体でも
30秒で完了する。(2) Staining time is extremely short. The acridine orange method stains for 5 minutes, but when RET exceeds 2 to 3%, it takes more than 10 minutes to complete staining. When staining with excess auramine O, even specimens with RET = 13%
Completes in 30 seconds.
(3) 蛍光強度が安定で染色後1時間程度は褪光し
ないから測定値の再現性・信頼性が高い。(3) Fluorescence intensity is stable and does not fade for about 1 hour after staining, so measurement values are highly reproducible and reliable.
第1図aは試料中の網状赤血球のRNA量と釣
合う分量のオーラミンOを含有する試薬量を用い
たときの血球細胞の蛍光染色状態を示すグラフ、
第1図bは本発明方法により過剰量のオーラミン
Oを使用した染色の示すaと同様のグラフ、第2
図は第1図a,bにそれぞれ対応する蛍光強度の
信号,を比較するグラフ、第3図,,
はアクリジンオレンジ法による第1図と同様のグ
ラフ、第4図は第3図に対応する第2図と同様の
グラフ、第5図,はピロニンY、チオフラビ
ンT法による第3図と同様のグラフである。
FIG. 1a is a graph showing the state of fluorescent staining of blood cells when using a reagent amount containing auramine O in an amount commensurate with the amount of reticulocyte RNA in the sample;
Figure 1b is a graph similar to that shown in a of staining using an excess amount of auramine O according to the method of the present invention;
The figure is a graph comparing the fluorescence intensity signals corresponding to Figure 1 a and b, respectively, Figure 3,...
Figure 4 is a graph similar to Figure 2 corresponding to Figure 3. Figure 5 is a graph similar to Figure 3 using the pyronine Y and thioflavin T method. It is.
Claims (1)
を用い、試料血球中のRNAを析出せしめるより
も過剰量の前記試薬によつて染色した試料に対
し、紫ないし青色の波長領域の光を光源より照射
し、前記試料からの螢光を測光することによつて
網状赤血球を測定することを特徴とする、フロー
サイトメータによる網状赤血球の測定方法。 2 特許請求の範囲1記載の方法において、前記
光源がアルゴン−イオンレーザであることを特徴
とするフローサイトメータによる網状赤血球の測
定方法。 3 特許請求の範囲第1記載の方法において、前
記光源がヘリウム−カドミウムレーザであること
を特徴とするフローサイトメータによる網状赤血
球の測定方法。 4 特許請求の範囲1記載の方法において、前記
光源が水銀アークランプであることを特徴とする
フローサイトメータによる網状赤血球の測定方
法。 5 特許請求の範囲1記載の方法において、前記
光源がキセノンアークランプであることを特徴と
するフローサイトメータによる網状赤血球の測定
方法。[Claims] 1. Using a fluorescent staining reagent for blood cells containing auramine O, a sample stained with an amount of the reagent in excess of the amount required to precipitate RNA in the sample blood cells is treated with a violet to blue wavelength. 1. A method for measuring reticulocytes using a flow cytometer, characterized in that reticulocytes are measured by irradiating a region with light from a light source and measuring fluorescence from the sample. 2. A method for measuring reticulocytes using a flow cytometer, wherein the light source is an argon-ion laser. 3. A method for measuring reticulocytes using a flow cytometer, wherein the light source is a helium-cadmium laser. 4. A method for measuring reticulocytes using a flow cytometer according to claim 1, wherein the light source is a mercury arc lamp. 5. A method for measuring reticulocytes using a flow cytometer, wherein the light source is a xenon arc lamp.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60173009A JPS6234058A (en) | 1985-08-06 | 1985-08-06 | Method for measuring reticulocyte by flow sight meter |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60173009A JPS6234058A (en) | 1985-08-06 | 1985-08-06 | Method for measuring reticulocyte by flow sight meter |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6234058A JPS6234058A (en) | 1987-02-14 |
| JPH0464588B2 true JPH0464588B2 (en) | 1992-10-15 |
Family
ID=15952502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60173009A Granted JPS6234058A (en) | 1985-08-06 | 1985-08-06 | Method for measuring reticulocyte by flow sight meter |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6234058A (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2549665B2 (en) * | 1987-07-31 | 1996-10-30 | 東亜医用電子株式会社 | Reticulocyte assay reagent for flow cytometry |
| JP3049254B2 (en) * | 1990-02-08 | 2000-06-05 | シスメックス株式会社 | Optical particle analyzer with two types of light sources |
| JPH05184742A (en) * | 1992-01-16 | 1993-07-27 | Kaijirushi Hamono Kaihatsu Center:Kk | Safety razor |
| DE69424079T2 (en) * | 1993-02-22 | 2000-09-07 | Sysmex Corp., Kobe | A reagent for the detection of malaria-infected cells and a detection method for malaria-infected cells using the same |
| JP5841315B2 (en) | 2010-04-28 | 2016-01-13 | ソニー株式会社 | Fine particle analyzer |
| JP5975074B2 (en) * | 2014-08-07 | 2016-08-23 | ソニー株式会社 | Data display method, program, data analysis apparatus, and fine particle analysis system |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4336029A (en) * | 1980-08-15 | 1982-06-22 | Ortho Diagnostic Systems Inc. | Method and reagents for quantitative determination of reticulocytes and platelets in whole blood |
-
1985
- 1985-08-06 JP JP60173009A patent/JPS6234058A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6234058A (en) | 1987-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0763201B1 (en) | Detection de réticulocytes avec la Coriphosphine O | |
| US5563070A (en) | Method of counting reticulocytes | |
| US5175109A (en) | Reagent for classifying leukocytes by flow cytometry | |
| US4985174A (en) | Reticulocyte quantitating reagent for flow cytometry | |
| US4957870A (en) | Detection of Reticulocytes, RNA and DNA | |
| CA2068471C (en) | Reagent and method for analyzing cells in urine | |
| US4883867A (en) | Detection of reticulocytes, RNA or DNA | |
| US4933293A (en) | Method of classifying leukocytes by flow cytometry and reagents used in the method | |
| JPS59195160A (en) | Fluorescent multi-parameter dispersoid analysis | |
| US4571388A (en) | Detection of reticulocytes | |
| EP0226272B1 (en) | Detection of reticulocytes | |
| US4707451A (en) | Detection of reticulocytes | |
| JP4454046B2 (en) | Method for detecting an analyte in a test sample using a helium-neon excitable dye | |
| JPH0464588B2 (en) | ||
| EP1918709B1 (en) | Analyzing method for platelets | |
| EP0259833A2 (en) | Reagent and method for classifying leukocytes by flow cytometry | |
| CN117233067B (en) | A white blood cell detection kit and its application | |
| JPH07333220A (en) | Reticulocyte measuring method and reticulocyte measuring apparatus | |
| CN118758823A (en) | A kit for white blood cell classification and counting and its application | |
| MXPA96005787A (en) | Detection of reticuloci | |
| JP2008111718A (en) | Platelet measuring reagent, platelet measuring reagent kit and platelet measuring method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |